Yu Fan Portfolio

Auto-discovered active 13F filer.

SEC 13F CIK: 0001668029

What is a 13F filing? Who files one and when · What 13F filings can't tell you

SmallFocusedHealth TiltHigh Turnover how tags are computed

Q2 2026 · 8 positions · Total reported value $107.92M · Top-10 concentration 100.0% · Updated 2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

Turnover: 25.0% · 0 new · 2 cut · 0 exited

Active Share (vs S&P 500): 100.0% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q1 2026 → Q2 2026): +17.4% · vs SPY +2.6% · Prev Value $97.02M — last quarter positions weighted by this quarter price moves · ranking

In its Q2 2026 13F filing, Yu Fan disclosed 8 equity positions with a combined reported value of $107.92M. The filing implies a focused portfolio: its ten largest positions account for 100.0% of reported value. HoldingsHub classifies the profile as Small / Focused / Health Tilt / High Turnover.

The largest disclosed positions as of Q2 2026 were KMTS ($58.07M), WHWK ($22.26M), ALMS ($7.11M). By sector, the heaviest allocations are Health Care 99.8%, Financials 0.2%.

Versus the prior quarter, Yu Fan opened 0 new positions, trimmed 2 and fully exited 0, a turnover rate of 25.0% of positions. The portfolio's overlap with the prior quarter was 100% of names.

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

Insider Transactions (Form 4)

Latest Yu Fan buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Yu Fan is an SEC-registered 13F filer. As of Q2 2026 it reported 8 US equity positions with a combined value of $107.92M. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Portfolio Structure

  • 8 positions · $107.92M reported value (Q2 2026)
  • Top 10 holdings = 100.0% of reported value
  • Largest position: KMTS (KESTRA MEDICAL TECHNOLOGIES) at 53.8%
  • Average position size: $13.49M

Sector Tilt

  • Health Care 99.8%
  • Financials 0.2%
  • (classified holdings cover 100% of value)

Quarterly Activity

  • Q2 2026: 1 added, 2 reduced
  • 5 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

AI Rebalance Analysis

1. Overall Direction and Market View: The fund appears to maintain a cautious stance with a focus on healthcare, reflecting a belief in the sector's long-term potential. The increase in healthcare holdings suggests a sector bias toward biotech and pharmaceuticals. 2. Key Moves: - Added: Whitehawk Therapeutics (W HWK) significantly, with a 134.8% increase in shares. This suggests a strategic move into a biotech company. - Reduced: Alumis Inc. (ALMS) and Ceribell Inc. (CBLL) were reduced by 67.5% and 37.7% respectively, indicating a shift away from certain biotech companies. - Hold: The majority of holdings were held steady, with no new additions, reflecting a conservative approach. 3. Portfolio Structure: - Passive/Active: The fund seems to be more passive, with a few active moves in key positions. - Sector Bias: Strong bias towards healthcare, particularly biotech and pharmaceuticals. - Risk Appetite: Moderate to low risk, as evidenced by the conservative hold strategy and minimal changes in positions. 4. Per-Holding One-Liner: - KMTS: Kestra Med Technology (Health Care - Biotechnology) - WHWK: Whitehawk Therapeutics (Health Care - Biotechnology) - ALMS: Alumis Inc. (Health Care - Biotechnology) - CBLL: Ceribell Inc. (Health Care - Biotechnology) - IVA: Inventiva SA (Health Care - Biotechnology) - PMN: Promis Neurosciences (Health Care - Biotechnology) - CATX: Perspective Therapeutics (Health Care - Biotechnology) - ABTC: American Bitcoin Corp. (Financials - Cryptocurrency) 5. One-Sentence Style Summary: Yu Fan Fund maintained a conservative approach in Q2 2026, focusing on healthcare sector investments, particularly biotech, with strategic additions and reductions in key holdings.

Generated by GLM-4.5-flash from the latest 13F holdings and quarter-over-quarter changes. For reference only, not investment advice.

Sector Allocation

Health Care 99.8%
Financials 0.2%
Sort by: Value Shares Weight Sector Change · CSV
# Shares Value Weight Allocation Change
1 2.28M $58.07M 53.81%
53.81%
Hold
2 4.86M $22.26M 20.63%
20.63%
Add
3 252.67K $7.11M 6.59%
6.59%
Reduce
4 342.40K $6.66M 6.17%
6.17%
Reduce
5 1.50M $5.67M 5.25%
5.25%
Hold
6 329.76K $4.34M 4.02%
4.02%
Hold
7 1.06M $3.60M 3.33%
3.33%
Hold
8 308.08K $209.83K 0.19%
0.19%
Hold

Holdings Prediction Model

Predicts next-quarter Top-10 holdings and weights from the fund's own historical trading轨迹 (add / reduce / hold) plus each stock's price momentum and relative volume. Strictly no look-ahead: a prediction for quarter T+1 uses only data through quarter T. Weights are shares of the modelled portfolio.

The next-quarter predicted Top 10 (2026-Q3) is shown in the «Latest Q · Forecast» tab above, in the same holdings format. That view is for logged-in accounts: 3 views per day on Free, unlimited on Gold/Diamond.

Latest-Quarter Accuracy (2026-Q2)

P 100% R 100% F1 100% (modelled on 2026-Q1; 8/10 hit)

Low-confidence forecast This fund replaces about 21% of its Top-10 each quarter and backtests at F1 79% (threshold 80%). Holdings in high-turnover portfolios cannot be forecast from their own history; the figures below are illustrative.

Historical Backtest (10 quarters)

Avg precision 83% · recall 78% · F1 79% · avg rank error 2.8 · Top-10 turnover 21%

Quarter Prec. Recall F1 Predicted Top 10 Actual Top 10
2024-Q1 50% 40% 44% CRGX · CSTL · SGMT · PYXS PRE · AGLE · SONX · SGMT · PYXS
2024-Q2 40% 33% 36% PRE · AGLE · SONX · SGMT · PYXS CGON · CRGX · ALMS · CSTL · PYXS · SGMT
2024-Q3 100% 100% 100% CGON · CRGX · ALMS · CSTL · PYXS · SGMT CRGX · ALMS · CGON · CSTL · PYXS · SGMT
2024-Q4 100% 86% 92% CRGX · ALMS · CGON · CSTL · PYXS · SGMT CBLL · CRGX · ALMS · CGON · CSTL · SGMT · PYXS
2025-Q1 100% 78% 88% CBLL · CRGX · ALMS · CGON · CSTL · SGMT · PYXS KMTS · CBLL · ALMS · CGON · CRGX · WHWK · CSTL · SGMT · PYXS
2025-Q2 56% 100% 71% KMTS · CBLL · ALMS · CGON · CRGX · WHWK · CSTL · SGMT · PYXS KMTS · CBLL · WHWK · CRGX · ALMS
2025-Q3 80% 100% 89% KMTS · CBLL · WHWK · CRGX · ALMS KMTS · CBLL · WHWK · ALMS
2025-Q4 100% 80% 89% KMTS · CBLL · WHWK · ALMS KMTS · CBLL · ALMS · IVA · WHWK
2026-Q1 100% 62% 77% KMTS · CBLL · ALMS · IVA · WHWK KMTS · ALMS · CBLL · IVA · WHWK · CATX · PMN · ABTC
2026-Q2 ★ 100% 100% 100% KMTS · ALMS · CBLL · IVA · WHWK · CATX · PMN · ABTC KMTS · WHWK · ALMS · CBLL · IVA · PMN · CATX · ABTC

★ = latest filed quarter (predicted vs actual). Recall = share of the real Top 10 caught by the model; precision = share of the predicted Top 10 that were real.

FAQ

What did Yu Fan buy in 2026-Q2?

In its 2026-Q2 13F filing, Yu Fan reported 8 equity positions worth $107.92M in aggregate; its largest disclosed positions were KMTS ($58.07M), WHWK ($22.26M), ALMS ($7.11M).

How large is Yu Fan's portfolio?

Yu Fan reported $107.92M of long equity holdings across 8 positions as of 2026-Q2. Top-10 holdings account for 100.0% of reported value.

What is Yu Fan's investment style?

HoldingsHub classifies the portfolio as Small / Focused / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/yu-fan/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →